Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2018 | 5 | 1.150 |
Why?
|
| Thrombosis | 2 | 2024 | 6 | 0.870 |
Why?
|
| Contactins | 1 | 2024 | 1 | 0.870 |
Why?
|
| Contactin 2 | 1 | 2024 | 1 | 0.870 |
Why?
|
| Sugars | 1 | 2024 | 2 | 0.870 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 1 | 0.820 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2022 | 1 | 0.790 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 10 | 0.700 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2021 | 32 | 0.690 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 58 | 0.670 |
Why?
|
| Membrane Proteins | 1 | 2021 | 49 | 0.660 |
Why?
|
| Fibrin | 3 | 2024 | 3 | 0.660 |
Why?
|
| Magnesium | 2 | 2018 | 7 | 0.640 |
Why?
|
| Manganese | 2 | 2024 | 6 | 0.630 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2018 | 4 | 0.600 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2018 | 2 | 0.580 |
Why?
|
| Coagulants | 1 | 2018 | 2 | 0.580 |
Why?
|
| Thromboplastin | 1 | 2018 | 2 | 0.580 |
Why?
|
| Protein Binding | 6 | 2024 | 118 | 0.570 |
Why?
|
| Gene Expression | 1 | 2018 | 52 | 0.560 |
Why?
|
| Fibrinogen | 2 | 2024 | 6 | 0.430 |
Why?
|
| Protein Conformation | 4 | 2024 | 46 | 0.420 |
Why?
|
| Humans | 13 | 2024 | 5476 | 0.410 |
Why?
|
| Ligands | 3 | 2023 | 55 | 0.360 |
Why?
|
| Protein Structure, Tertiary | 3 | 2022 | 30 | 0.340 |
Why?
|
| Macrophage-1 Antigen | 2 | 2021 | 3 | 0.330 |
Why?
|
| Glycosylation | 3 | 2024 | 11 | 0.320 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 54 | 0.300 |
Why?
|
| Protein Folding | 1 | 2007 | 15 | 0.280 |
Why?
|
| Integrin beta1 | 1 | 2007 | 10 | 0.280 |
Why?
|
| Binding Sites | 3 | 2024 | 69 | 0.230 |
Why?
|
| Blood Coagulation | 1 | 2024 | 2 | 0.230 |
Why?
|
| HEK293 Cells | 3 | 2021 | 32 | 0.230 |
Why?
|
| von Willebrand Factor | 1 | 2024 | 2 | 0.220 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2024 | 1 | 0.220 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 4 | 0.220 |
Why?
|
| Molecular Conformation | 2 | 2023 | 27 | 0.220 |
Why?
|
| Corneal Injuries | 1 | 2023 | 7 | 0.210 |
Why?
|
| Epithelium, Corneal | 1 | 2023 | 13 | 0.210 |
Why?
|
| Inteins | 1 | 2023 | 3 | 0.200 |
Why?
|
| Staphylococcus aureus | 1 | 2023 | 20 | 0.200 |
Why?
|
| Cations, Divalent | 1 | 2022 | 4 | 0.200 |
Why?
|
| Models, Molecular | 3 | 2024 | 87 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 14 | 0.190 |
Why?
|
| Neutrophils | 2 | 2018 | 19 | 0.180 |
Why?
|
| Complement C3b | 1 | 2021 | 1 | 0.180 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 11 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 17 | 0.180 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 17 | 0.180 |
Why?
|
| Porins | 1 | 2021 | 4 | 0.180 |
Why?
|
| Proteomics | 1 | 2021 | 23 | 0.170 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 21 | 0.170 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 55 | 0.170 |
Why?
|
| RNA, Messenger | 1 | 2021 | 69 | 0.170 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 68 | 0.160 |
Why?
|
| Receptors, IgG | 1 | 2018 | 4 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 6 | 0.150 |
Why?
|
| Proteolysis | 1 | 2018 | 7 | 0.150 |
Why?
|
| Protein Structure, Quaternary | 1 | 2018 | 6 | 0.150 |
Why?
|
| X-Ray Diffraction | 1 | 2018 | 9 | 0.150 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 5 | 0.150 |
Why?
|
| Protein Domains | 1 | 2018 | 18 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2018 | 11 | 0.140 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 3 | 0.140 |
Why?
|
| CD18 Antigens | 1 | 2017 | 4 | 0.140 |
Why?
|
| Pneumonia | 1 | 2017 | 20 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 19 | 0.130 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 34 | 0.130 |
Why?
|
| Allosteric Site | 1 | 2016 | 1 | 0.130 |
Why?
|
| Consensus Sequence | 1 | 2016 | 1 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 7 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 10 | 0.130 |
Why?
|
| Leukocytes | 1 | 2016 | 6 | 0.130 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 7 | 0.130 |
Why?
|
| Sequence Alignment | 1 | 2016 | 20 | 0.130 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 50 | 0.120 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 38 | 0.120 |
Why?
|
| Motion | 1 | 2016 | 22 | 0.120 |
Why?
|
| Animals | 4 | 2024 | 1817 | 0.110 |
Why?
|
| Wound Healing | 2 | 2024 | 15 | 0.110 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 26 | 0.100 |
Why?
|
| Mice | 2 | 2023 | 719 | 0.070 |
Why?
|
| Chromatography, Gel | 1 | 2007 | 3 | 0.070 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 8 | 0.070 |
Why?
|
| Hydrogen Bonding | 1 | 2007 | 19 | 0.070 |
Why?
|
| Dimerization | 1 | 2007 | 14 | 0.070 |
Why?
|
| Calcium | 1 | 2007 | 30 | 0.070 |
Why?
|
| Thermodynamics | 2 | 2023 | 42 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 10 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2024 | 15 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 44 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2024 | 23 | 0.060 |
Why?
|
| von Willebrand Disease, Type 3 | 1 | 2024 | 1 | 0.060 |
Why?
|
| Integrin alpha2 | 1 | 2024 | 1 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2024 | 3 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2024 | 37 | 0.050 |
Why?
|
| Protein Multimerization | 1 | 2024 | 16 | 0.050 |
Why?
|
| Lumican | 1 | 2023 | 1 | 0.050 |
Why?
|
| Calorimetry | 1 | 2023 | 8 | 0.050 |
Why?
|
| Peptides | 1 | 2023 | 51 | 0.050 |
Why?
|
| Cornea | 1 | 2023 | 140 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 4 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 63 | 0.040 |
Why?
|
| Basement Membrane | 1 | 2018 | 3 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 6 | 0.040 |
Why?
|
| Nephritis | 1 | 2018 | 2 | 0.040 |
Why?
|
| Endothelium | 1 | 2018 | 4 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 4 | 0.030 |
Why?
|
| Phthalic Acids | 1 | 2017 | 2 | 0.030 |
Why?
|
| beta-Alanine | 1 | 2017 | 2 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 9 | 0.030 |
Why?
|
| Lung | 1 | 2017 | 42 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 195 | 0.030 |
Why?
|
| Male | 1 | 2018 | 2765 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 13 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 19 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 79 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 86 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 131 | 0.020 |
Why?
|